-
THE DIFFERENTIAL IMPACT OF FAMILY-LEVEL MULTIMORBIDITY ON FINANCIAL HARDSHIP BY INSURANCE STATUS EVIDENCE FROM MEPS 2018-2023
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS AND VALUE MATRIX IN A STRUCTURED MODEL FOR THE PROVISION OF IMMUNOBIOLOGIC THERAPIES IN DERMATOLOGY: A REAL-WORLD ANALYSIS
Feb 25, 2026, 14:41 PM -
FINANCIAL COSTS OF PROVIDING ORAL PRE- AND POST-EXPOSURE PROPHYLAXIS VIA PHARMACIES IN KENYA
Feb 25, 2026, 14:40 PM -
USING UNANNOUNCED STANDARDIZED PATIENTS TO ASSESS QUALITY OF TUBERCULOSIS CARE AND ANTIBIOTIC PRESCRIBING: A CROSS-SECTIONAL STUDY FROM LOW-MIDDLE INCOME COUNTRY, PAKISTAN
Feb 25, 2026, 14:40 PM -
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND RISK OF PARKINSON’S DISEASE IN PATIENTS WITH OBESITY
Feb 25, 2026, 14:40 PM -
MAPPING HUMAN EFFORT DISPLACEMENT IN AI-ASSISTED HEOR WORKFLOWS
Feb 25, 2026, 14:40 PM -
PREDICTORS OF PATIENT-DIRECTED DISCHARGE AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER
Feb 25, 2026, 14:40 PM -
HISTORIC PRICE DIFFERENTIALS AND MOST-FAVORED NATION PRESCRIPTION DRUG PRICING POLICY IMPACT: SCENARIO ANALYSIS USING POLI DATA ACROSS EIGHT GLOBAL MARKETS
Feb 25, 2026, 14:40 PM -
GEOGRAPHIC DISPARITIES IN TREATMENT ACCESS FOR TEXAS MEDICAID PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Feb 25, 2026, 14:40 PM -
IMPACT OF TAFAMIDIS USE IN COLOMBIAN PATIENTS DIAGNOSED WITH ATTR-CM ON HEALTH-RELATED QUALITY OF LIFE DURING TWO YEARS OF FOLLOW-UP: REAL WORLD STUDY IN COLOMBIA
Feb 25, 2026, 14:40 PM -
INCIDENT INSOMNIA AND STRESS-RELATED MENTAL HEALTH OUTCOMES AFTER NUTRITIONAL SUPPLEMENT INITIATION IN ADULTS WITH TYPE 2 DIABETES: A MULTI-TIME-WINDOW COHORT STUDY USING THE TRINETX GLOBAL COLLABORATIVE NETWORK
Feb 25, 2026, 14:40 PM -
UNPAID ELDER CAREGIVING AND LABOR MARKET OUTCOMES IN THE UNITED STATES, 2011 TO 2024
Feb 25, 2026, 14:40 PM -
CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS
Feb 25, 2026, 14:40 PM -
PATIENT PREFERENCES FOR TREATMENT SELECTION IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): A SYSTEMATIC LITERATURE REVIEW (SLR)
Feb 25, 2026, 14:40 PM -
COST EFFECTIVENESS OF DIGITAL HEMOGLOBINOMETERS FOR SCREENING ANEMIA IN COMMUNITY SETTINGS
Feb 25, 2026, 14:40 PM -
GOAL INVENTORIES IN STANDARDIZED IMPLEMENTATION OF PERSONALIZED OUTCOME ASSESSMENTS USING GOAL ATTAINMENT SCALING: A LANDSCAPE ANALYSIS
Feb 25, 2026, 14:40 PM -
A MULTI-DIMENSIONAL WEIGHTING METHODOLOGY FOR EVALUATING PATIENT-REPORTED OUTCOME EVIDENCE TO OPTIMIZE AND DIFFERENTIATE A MARKETED TREATMENT
Feb 25, 2026, 14:40 PM -
ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Feb 25, 2026, 14:40 PM -
COST-EFFECTIVENESS ANALYSIS OF ENCORAFENIB IN UNTREATED BRAF V600E-MUTANT METASTATIC COLORECTAL CANCER IN CHINA
Feb 25, 2026, 14:40 PM -
A COMPREHENSIVE GLOBAL SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF RELAPSED/REFRACTORY AND POST-BRUTON TYROSINE KINASE INHIBITOR MANTLE CELL LYMPHOMA
Feb 25, 2026, 14:40 PM
